Candriam S.C.A. Invests $4.93 Million in Omega Healthcare Investors, Inc. $OHI

Candriam S.C.A. bought a new position in Omega Healthcare Investors, Inc. (NYSE:OHI) in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 129,513 shares of the real estate investment trust’s stock, valued at approximately $4,932,000.

Several other institutional investors and hedge funds also recently modified their holdings of OHI. NBC Securities Inc. purchased a new stake in shares of Omega Healthcare Investors in the first quarter worth about $29,000. Dunhill Financial LLC boosted its position in shares of Omega Healthcare Investors by 97.9% in the fourth quarter. Dunhill Financial LLC now owns 1,516 shares of the real estate investment trust’s stock worth $57,000 after buying an additional 750 shares during the period. CoreCap Advisors LLC boosted its holdings in Omega Healthcare Investors by 177.3% in the fourth quarter. CoreCap Advisors LLC now owns 1,578 shares of the real estate investment trust’s stock valued at $60,000 after purchasing an additional 1,009 shares during the last quarter. Park Square Financial Group LLC purchased a new position in Omega Healthcare Investors in the fourth quarter valued at about $61,000. Finally, UMB Bank n.a. boosted its holdings in Omega Healthcare Investors by 94.9% in the first quarter. UMB Bank n.a. now owns 2,175 shares of the real estate investment trust’s stock valued at $83,000 after purchasing an additional 1,059 shares during the last quarter. Hedge funds and other institutional investors own 65.25% of the company’s stock.

Omega Healthcare Investors Trading Down 0.4%

Shares of NYSE OHI opened at $42.20 on Friday. The stock’s 50 day moving average price is $38.50 and its two-hundred day moving average price is $37.61. Omega Healthcare Investors, Inc. has a 52-week low of $35.04 and a 52-week high of $44.42. The stock has a market capitalization of $12.45 billion, a P/E ratio of 26.05, a PEG ratio of 2.25 and a beta of 0.66. The company has a quick ratio of 7.10, a current ratio of 7.10 and a debt-to-equity ratio of 0.96.

Omega Healthcare Investors (NYSE:OHI) last announced its quarterly earnings data on Thursday, July 31st. The real estate investment trust reported $0.77 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.45 by $0.32. Omega Healthcare Investors had a return on equity of 9.78% and a net margin of 42.23%.The firm had revenue of $235.60 million for the quarter, compared to analysts’ expectations of $248.49 million. During the same quarter in the prior year, the firm posted $0.71 earnings per share. Omega Healthcare Investors’s revenue for the quarter was up 11.8% compared to the same quarter last year. Omega Healthcare Investors has set its FY 2025 guidance at 3.040-3.070 EPS. On average, analysts anticipate that Omega Healthcare Investors, Inc. will post 2.86 earnings per share for the current fiscal year.

Omega Healthcare Investors Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, August 15th. Shareholders of record on Monday, August 4th were paid a dividend of $0.67 per share. The ex-dividend date was Monday, August 4th. This represents a $2.68 annualized dividend and a yield of 6.4%. Omega Healthcare Investors’s dividend payout ratio is presently 165.43%.

Analyst Upgrades and Downgrades

A number of research analysts recently commented on the company. Royal Bank Of Canada increased their price target on Omega Healthcare Investors from $39.00 to $41.00 and gave the company a “sector perform” rating in a report on Thursday, August 7th. Wells Fargo & Company raised Omega Healthcare Investors from an “equal weight” rating to an “overweight” rating and increased their price target for the company from $38.00 to $41.00 in a report on Monday, July 14th. Four equities research analysts have rated the stock with a Buy rating and five have given a Hold rating to the company. According to data from MarketBeat, the company currently has an average rating of “Hold” and a consensus price target of $42.00.

Insider Transactions at Omega Healthcare Investors

In other Omega Healthcare Investors news, Director Lisa Egbuonu-Davis sold 2,500 shares of the company’s stock in a transaction that occurred on Friday, August 8th. The stock was sold at an average price of $40.16, for a total transaction of $100,400.00. Following the sale, the director owned 18,654 shares in the company, valued at $749,144.64. This represents a 11.82% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. 1.50% of the stock is owned by insiders.

Omega Healthcare Investors Profile

Omega Healthcare Investors, Inc engages in the provision of financing and capital to the long-term healthcare industry with a particular focus on skilled nursing facilities, assisted living facilities, independent living facilities, rehabilitation and acute care facilities, and medical office buildings.